SHAREHOLDERS' EQUITY (Tables)

3 Months Ended

Mar. 31, 2026

Equity [Abstract]

Schedule of Stock-Based Compensation Expense

The following table summarizes the stock-based compensation expense incurred by the Company for the three months ended March 31, 2026 and 2025:

	Three Months Ended March 31,
	2026		2025
Stock-based compensation	$	369,962	$	243,621

Schedule of Nonvested Share Activity

The following table summarizes restricted stock (i) converted, (ii) granted, (iii) vested and (iv) forfeited for the Company’s directors and officers and employees of the Manager as of March 31, 2026 and December 31, 2025:

	As of
	March 31, 2026	December 31, 2025
Converted	88,685	88,685
Granted	233,938	135,269
Vested	(127,231)	(76,350)
Forfeited	(3,315)	(3,315)
Balance	192,077	144,289

Schedule of Restricted Stock Awards Activity

The fair value of the Company’s restricted stock awards is based on the Company’s stock price on the date of grant. The following tables summarize the restricted stock activity as of and during the three months ended March 31, 2026:

	Number of shares of restricted stock	Weighted-average grant date fair value
Balance as of December 31, 2025	144,289	$	12.88
Granted	98,669	9.34
Vested	(50,881)	11.93
Forfeited	—	—
Balance as of March 31, 2026	192,077	$	11.31